June 19, 2007 - A study published today in Circulation shows that the use of NT-proBNP (N-terminal proB-type natriuretic peptide), a biomarker by Roche Diagnostics for suspected heart failure (HF), reduced emergency department (ED) visits by 21 percent.

June 19, 2007 – Cardica Inc. and Cook Medical today announced that they have entered into an agreement to develop and commercialize a specialized device designed to close the patent foramen ovale (PFO), a relatively common heart defect present in approximately 15 to 20 percent of the general population, which targets patients at risk for stroke or systemic embolism.

June 18, 2007 – BioServe today announced that it has been selected by Houston-based Specialized Clinical Center of Research (SCCOR) for a novel study aimed at identifying the genetic cause of thoracic aortic disease, in which the company will provide SCCOR researchers with access to unique sample sets from its Global Repository of over 600,000 human DNA, tissue and serum samples linked to detail

June 18, 2007 - Siemens Medical Solutions Ultrasound Division is showcasing its comprehensive cardiovascular risk assessment solutions on its ACUSON X300 ultrasound platform at the 18th Annual Scientific Sessions of the American Society of Echocardiography (ASE), in Seattle, with the purpose of testing patients’ vascular age.
The company’s syngo Arterial Health Package (AHP) for cardiovascular risk assessment provides semi-automated quantification tools for users that help to assess the cardiovascular risk potential of patients using the concept of “vascular age.”

June 15, 2007 — Johnson & Johnson says U.S. regulators have ended almost three years of sanctions over manufacturing quality that limited the company's ability to sell drug-coated heart stents.

The FDA notified Cordis Corp., a unit of Johnson & Johnson, that it had lifted a warning letter that had been issued in 2004. The letter dealt with quality assurance at seven manufacturing plants.